AlloCure allocure.com


AlloCure is a biotechnology company developing the use of cell therapy for the treatment of kidney disease. AlloCure's technology allows for the isolation and expansion of a specific population of mesenchymal stem cells obtained via conventional bone marrow donation. AlloCure's cells are not recognized by the immune system enabling them to be administered in an off-the-shelf fashion to any patient in need.

AlloCure is a biotechnology company developing the use of cell therapy for the treatment of kidney disease. AlloCure's technology allows for the isolation and expansion of a specific population of mesenchymal stem cells obtained via conventional bone...Show all

Company (Alive / Active)

Phone: 801-583-8450

Fax:

25 Corporate Drive
Suite 360
Burlington, 01803
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
AlloCure $48.7M Dec 23, 2013
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related AlloCure Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors

Competitors

Company Status Description Investors

Stemina Biomarker Discovery

Madison, Wisconsin, United States
Alive / ActiveStemina Cell Discovery discovers and validates small molecules as biomarkers for high-throughput drug screening and disease diagnostics using an all human system comprised of stem cells and the company's metabolomics platform. Metabolomics aims to enable the discovery of small molecules that can be used as candidate biomarkers of disease and pharmacological efficacy or toxicity. The human embryonic stem cell metabolome is a source of candidate biomarkers to predict, diagnose or measure the progr...Show allLogin to see details

Corthera

San Mateo, California, United States
AcquiredCorthera Inc. is a private biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in clinical trials for the treatment of acute heart failure. The company has worldwide rights to develop and commercialize relaxin. For more information, visit www.corthera.com. Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodil...Show allLogin to see details
See all 16 competitors